1793.5000 -13.70 (-0.76%)
NSE Dec 12, 2025 15:57 PM
Volume: 1.4M
 

1793.50
-0.76%
Motilal Oswal
Sun Pharma (SUNP) delivered in-line revenue/EBITDA in 2QFY26. Earnings came in below our estimates largely due to lower other income.
Number of FII/FPI investors decreased from 1326 to 1225 in Sep 2025 qtr
More from Sun Pharmaceutical Industries Ltd.
Recommended